Home Delivery Service - Home Parenteral Nutrition

This planned procurement process is initiated by NHS England, aiming to establish a National Framework Agreement for a Home Delivery Service concerning Pulmonary Hypertension Drugs. Categorised under the services industry, this procurement is set in London, United Kingdom, with important dates including a publication date of 21st May 2025 and a future notice expected on 1st November 2026. The procurement planning stage currently focuses on preparing for a tender initiation that aligns with legal frameworks stipulated by the UKPGA 2023/54.

The contract period is slated to commence on 1st April 2027, extending until 31st March 2029, with an option for renewal potentially until 2031. This tender presents a significant opportunity for businesses, especially SMEs, specialising in home medical treatment services to expand their operations and establish partnerships within the healthcare sector. With a gross value of £355,200,000, this substantial investment underscores possibilities for growth for companies that can offer efficient delivery and support services for home parenteral nutrition.

Suitably positioned service providers with expertise in managing frameworks for central government authorities are well-suited to compete in this planned procurement, offering their innovations and proven capabilities to enhance NHS England’s service delivery for pulmonary hypertension treatment.